Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
Salt CompositionMetformin 500mg + Voglibose 0.2mg
You Searched
Voglihop-M 0.2 Tablet ER
Anax Lifescience
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Treatment of Type 2 diabetes mellitus
Customers also bought
More About Voglihop-M
Benefits
In Treatment of Type 2 diabetes mellitus Voglihop-M 0.2 Tablet ER is a medicine that helps to control high blood glucose (sugar) levels. It helps to slow down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals. It also helps get rid of extra glucose from your body through urine. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems and loss of limbs. Voglihop-M 0.2 Tablet ER will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Voglihop-M 0.2 Tablet ER is to be taken with food.
How it works
Voglihop-M 0.2 Tablet ER is a combination of two antidiabetic medicines: Metformin and voglibose. Metformin lowers the production and absorption of sugar in your body and allows better use of existing insulin. Voglibose inhibits the intestinal enzymes that cause breakdown of complex sugars into simple sugars such as glucose. This prevents blood glucose from rising very high after meals.
Unsafe: Avoid consuming alcohol with Voglihop-M 0.2 Tablet ER as it is deemed unsafe.
Seek medical advice from your doctor: Voglihop-M 0.2 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Voglihop-M 0.2 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
SAFE - Voglihop-M 0.2 Tablet ER does not usually affect your ability to drive. However, patients should be alerted to the risk of hypoglycemia when it is used in combination with other antidiabetic agents such as sulfonylureas, insulin, and repaglinide.
Caution Advised: Voglihop-M 0.2 Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Voglihop-M 0.2 Tablet ER may be needed. Doctor consultation is advised. Use of Voglihop-M 0.2 Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Seek medical advice from your doctor: There is limited information available on the use of Voglihop-M 0.2 Tablet ER in patients with liver disease. Doctor consultation is advised.
What if I forget to take it?
If a dose of Voglihop-M 0.2 Tablet ER is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
11,Anax Life science, Purshotamnagar, Nr. Pink City, Ranip, Ahmedabad-382480
References
CiplaMed. Voglibose + Metformin hydrochloride (08 Apr. 2019)
Metformin hydrochloride. Princeton, New Jersey: Bristol-Myers Squibb Company (08 Apr. 2019)
Metformin hydrochloride oral solution. Gloversville, New York: Ranbaxy Pharmaceuticals Inc.; 2003 (08 Apr. 2019)
Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An Alpha Glucosidase Inhibitor. J Clin Diagn Res. 2013;7(12):3023-7 (08 Apr. 2019)
Metformin hydrochloride and Voglibose (Tablets) (21 Oct. 2021)
Voglibose and Metformin Hydrochloride Tablets (28th Sept. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
